Answers are grounded in this paper and cite their sources.
Signal peptide peptidase (SPP) is an endoplasmic-reticulum intramembrane aspartyl protease required for hepatitis C virus (HCV) core protein maturation, but many SPP inhibitors also inhibit γ-secretase. Here, we designed YO-01027-derived dibenzazepinone analogs to retain SPP inhibition while reducing γ-secretase liability. An initial set of analogs was evaluated using an AcGFP–HCV core reporter assay and an APPsw/Aβ production assay. SPP5 suppressed HCV core processing while showing a reduced effect on Aβ production relative to YO-01027. Among a subsequent structurally diverse set of analogs related to YO-01027 and SPP5, SPP17 reduced SPP-dependent core maturation, HCV propagation, infectious virus production, and NS5A-positive foci in Huh7 cells, while showing attenuated γ-secretase inhibition and no apparent cytotoxicity under the tested conditions. These results demonstrate that γ-secretase inhibitor scaffolds can be tuned to generate SPP-directed antiviral chemical probes.
No takes yet. Share an insight, caveat, or question.
Yokoo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: